Story perspectives

German Woman Achieves Year-Long Remission After CAR T-Cell Therapy

4/9/2026

Summary

Story summary

A 47-year-old woman in Germany achieved treatment-free remission for over a year after CAR T-cell therapy for three life-threatening autoimmune diseases, including autoimmune hemolytic anemia and antiphospholipid syndrome, with findings published in Med.
The CAR T-cell therapy reset her immune system by targeting dysfunctional B-cells.
She previously depended on daily blood transfusions.
Experts say further clinical trials are needed to assess long-term safety and effectiveness.

1 of 1

Story summary

A 47-year-old woman in Germany achieved treatment-free remission for over a year after CAR T-cell therapy for three life-threatening autoimmune diseases, including autoimmune hemolytic anemia and antiphospholipid syndrome, with findings published in Med.
The CAR T-cell therapy reset her immune system by targeting dysfunctional B-cells.
She previously depended on daily blood transfusions.
Experts say further clinical trials are needed to assess long-term safety and effectiveness.